Data from multiple sources indicate that most of the growth in private funding in life sciences has been driven by late-stage financings and crossover investors rather than by traditional venture capital.

BioHubble aims to address this market gap by providing fluid, transparent and actionable information access to both investors and biopreneurs.

Investors may be early stage or angel who are willing to take a risk and finance a promising early stage life sciences start-up.

COMPANY
PRODUCT
SOLUTIONS
SERVICES